Wound Culture: Indications, Technique, and Empiric Therapy
Obtain wound cultures only for clinically infected wounds—never for uninfected wounds—using deep tissue specimens obtained by curettage or biopsy after thorough cleansing and debridement, while avoiding superficial swabs that yield unreliable results. 1
When to Culture
Do NOT culture:
- Clinically uninfected wounds - cultures are not indicated and should not be performed 1
- Wounds without signs of infection being treated prophylactically
DO culture when:
- Clinical infection is present with signs including:
- Purulent drainage
- Erythema, warmth, swelling
- Pain or tenderness
- Delayed healing or wound deterioration
- Necrotic tissue
- Systemic signs (fever, elevated WBC)
Exception where cultures may be unnecessary:
- Mild infections in antibiotic-naive patients at low risk for MRSA can be treated empirically without cultures 1
- These predictably involve only staphylococci and streptococci
Critical timing: Obtain cultures before initiating empiric antibiotics whenever possible, as this is essential for detecting multidrug-resistant organisms (MRSA, ESBL-producing gram-negatives, resistant Pseudomonas) 1
How to Obtain Cultures Using Aseptic Technique
The Proper Method (in order):
- Cleanse the wound thoroughly - remove surface debris and contaminants
- Debride necrotic tissue - remove all non-viable material from the wound bed
- Obtain deep tissue specimen by one of these methods:
What to AVOID:
- Superficial swabs of undebrided wounds - these provide less accurate results and often yield contaminants 1, 2, 1
- If swabbing is the only option, use the Levine technique (rotate swab over 1 cm² area with sufficient pressure to express fluid from wound tissue) rather than Z-technique 4, 3
Specimen handling:
- Place in sterile container or appropriate transport media
- Request both aerobic and anaerobic cultures
- Clearly label specimen type and anatomic location
- Transport promptly to laboratory 2
Additional cultures:
- Blood cultures for severe infections, especially if systemically ill 2
Empiric Antimicrobial Therapy
Mild to Moderate Infections (antibiotic-naive patients):
Target aerobic gram-positive cocci only - Staphylococcus aureus and streptococci are the predominant pathogens 1
- Oral agents with high bioavailability are sufficient
- Examples: cephalexin, dicloxacillin, or amoxicillin-clavulanate
Severe Infections:
Start broad-spectrum parenteral therapy pending culture results 1
- Must cover gram-positive cocci, gram-negative rods, and anaerobes
- Examples: piperacillin-tazobactam, carbapenems, or combination therapy
MRSA Coverage - Consider when:
- Prior history of MRSA infection
- High local MRSA prevalence
- Clinically severe infection
- Recent antibiotic exposure 1
Add vancomycin, linezolid, or daptomycin to regimen
Pseudomonas Coverage:
Usually unnecessary except for patients with specific risk factors 1:
- Warm, moist wounds
- Recent broad-spectrum antibiotic use
- Healthcare-associated infections
Route of Administration:
- Parenteral: All severe infections, some moderate infections initially 1
- Oral: Most mild and many moderate infections (use highly bioavailable agents) 1
- Switch from IV to oral when patient is systemically stable and culture results available
Critical Pitfalls to Avoid
- Culturing uninfected wounds - wastes resources, promotes resistance, provides misleading data
- Using superficial swabs - yields colonizing organisms rather than true pathogens
- Culturing before debridement - captures surface contaminants
- Starting antibiotics before obtaining cultures - prevents identification of resistant organisms
- Empiric Pseudomonas coverage in all cases - unnecessarily broad, promotes resistance
- Treating culture results rather than clinical response - colonization vs. infection distinction matters
Definitive Therapy
Base final antibiotic selection on culture results AND clinical response [1, @22@]. Narrow spectrum when possible once sensitivities return. Duration typically 1-2 weeks for mild infections, 2-3 weeks for moderate-to-severe soft tissue infections 1.